Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status

Prostate

Volumn 36, Issue SUPPL. 8, 1998, Pages 18-22

  Bonkhoff, Helmut ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Androgen receptor; Morphogenesis; Neuroendocrine differentiation; Prognosis; Proliferation; Prostate; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; CELL NUCLEUS RECEPTOR; CHROMOGRANIN A; MONOCLONAL ANTIBODY KI 67;

ARTICLE; BENIGN TUMOR; CANCER HORMONE THERAPY; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MORPHOGENESIS; NEUROSECRETORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; ADENOCARCINOMA; CELL DIVISION; CYTOLOGY; NEUROSECRETION; PATHOLOGY; PRENATAL DEVELOPMENT; PROSTATE; PROSTATE TUMOR; REVIEW; STEM CELL;

ADENOCARCINOMA; CELL DIVISION; HUMANS; MALE; MORPHOGENESIS; NEUROSECRETORY SYSTEMS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STEM CELLS;

EID: 26844531799     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(1998)8+<18::AID-PROS4>3.0.CO;2-C     Document Type: Article

References (21)

1. Di Sant'Agnese P: Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic and therapeutic implications. Cancer 1992;70:254-268.
2. Di Sant'Agnese P: Neuroendocrine differentiation in prostatic carcinoma. Recent findings and new concepts. Cancer 1995;75: 1850-1859.
3. Di Sant'Agnese P, Cockett AT: Neuroendocrine differentiation in prostatic malignancy. Cancer 1996;78:357-361.
4. Bologna M, Festuccia C, Muzi P, Biordi L, Ciomeni M: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989;63:1714-1720.
5. Iwamura M, Wu G, Abrahamsson PA, Cockett A, Foss K, Deftos L: Parathyroid hormone-related protein: A potential autocrine growth regulator in human prostate cancer cell lines. Urology 1994;43:675-679.
6. Shah G, Rayford W, Noble M, Austenfeld M, Weigel J, Vamos S, Mebust W: Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3′,5′-monophosphates and cytoplasmic Ca2 transients. Endocrinology 1994;134:596-602.
7. Cohen R, Glezerson O, Haffejee Z: Neuroendocrine cells: A new prognostic parameter in prostate cancer. Br J Urol 1991;68:258-262.
8. Weinstein MH, Partin AW, Veltri RW, Epstein JI: Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progession after radical prostatectomy. Hum Pathol 1996;27: 683-687.
9. Grignon D, Caplan R, Sakr W, Porter A, Doggen RLS, John M, Abrams R, Lawton C: Neuroendocrine (NE) differentiation as a prognostic indicator in locally advanced prostate cancer (PCa). Lab Invest 1995;72:76A.
10. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate. Simultaneous demonstration of cell specific epithelial markers. Hum Pathol 1994;25:42-46.
11. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28:98-106.
12. Bonkhoff H: Role of the basal cells in premalignant changes of the human prostate: A stem cell concept for the development of prostate cancer. Eur Urol 1996;30:201-205.
13. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994;24:224-118.
14. Bonkhoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic and neoplastic human prostate. Prostate 1991;18:91-98.
15. Bonkhoff H, Stein U, Remberger K: Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 1995;26:167-170.
16. Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic and neoplastic human prostate. Virchows Arch A Pathol Anat 1993; 423:291-294.
17. Krijnen J, Janssen P, Ruizeveld de Winter JA, van Kimpen H, Schröder F, van der Kwast T: Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry 1993;100:393-398.
18. Gittes RF: Carcinoma of the prostate. N Engl J Med 1991;324: 236-245.
19. Ruizeveld de Winter JA, Janssen PJA, Sleddens HM, Verleum-Mooijman MCT, Trapman J, Brinkmann AO, Samerse AB, Schroeder FH, Van der Kwast TH: Androgen receptor status in localized and locally progressive, hormone refractory human prostate cancer. Am J Pathol 1994;144:735-746.
20. Bonkhoff H, Stein U, Aumüller G, Remberger K: Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinoma. Prostate 1996;29:261-267.
21. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 1995;9:401-106.